Table 1.
Participant No. | s01 | s02 | s03 | s04 | s05 | s06 | s07 | s08 | s09 | s10 | s11 | s12 | s13 | s14 | s15 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pos-Neg | 76.7 | 80.0 | 93.3 | 86.7 | 96.7 | 90.0 | 93.3 | 100.0 | 96.7 | 96.7 | 100.0 | 80.0 | 93.3 | 90.0 | 100.0 |
Pos-Neu-Neg | 77.8 | 57.8 | 93.3 | 82.2 | 84.4 | 80.0 | 80.0 | 91.1 | 84.4 | 71.1 | 75.6 | 86.7 | 62.2 | 71.1 | 95.6 |
Participant numbers (s01–s15) correspond to each test data of the 15-fold cross-validation.